tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KURA Stock Latest News

Promising Developments in Kura Oncology’s FTI Programs Highlighted by Analyst Buy Rating
RatingsPromising Developments in Kura Oncology’s FTI Programs Highlighted by Analyst Buy Rating
2d ago
KURA
Kura Oncology’s Strategic Positioning and Promising Developments Justify Buy Rating
PremiumRatings
Kura Oncology’s Strategic Positioning and Promising Developments Justify Buy Rating
2d ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
14d ago
KURA
Kura Oncology initiated with a Neutral at Guggenheim
PremiumThe Fly
Kura Oncology initiated with a Neutral at Guggenheim
15d ago
KURA
Kura Oncology initiated with a Neutral at Guggenheim
PremiumThe Fly
Kura Oncology initiated with a Neutral at Guggenheim
15d ago
KURA
Optimistic Buy Rating for Kura Oncology: KO-2806’s Potential in ccRCC and Market Opportunities
PremiumRatingsOptimistic Buy Rating for Kura Oncology: KO-2806’s Potential in ccRCC and Market Opportunities
17d ago
KURA
Kura Oncology’s KO-2806: A Promising Investment with $1.5 Billion Market Potential in RCC
Premium
Ratings
Kura Oncology’s KO-2806: A Promising Investment with $1.5 Billion Market Potential in RCC
28d ago
KURA
Kura Oncology’s Earnings Call: Progress Amidst Challenges
Premium
Company Announcements
Kura Oncology’s Earnings Call: Progress Amidst Challenges
1M ago
KURA
Kura Oncology price target lowered to $24 from $28 at Citizens JMP
PremiumThe Fly
Kura Oncology price target lowered to $24 from $28 at Citizens JMP
1M ago
KURA
Kura Oncology price target lowered to $27 from $29 at BofA
PremiumThe Fly
Kura Oncology price target lowered to $27 from $29 at BofA
1M ago
KURA
Kura Oncology’s Promising Future: Strong Financials and Advancements in AML Treatment Drive Buy Rating
PremiumRatings
Kura Oncology’s Promising Future: Strong Financials and Advancements in AML Treatment Drive Buy Rating
1M ago
KURA
Kura Oncology Advances Cancer Drug Pipeline with FDA Review
PremiumCompany Announcements
Kura Oncology Advances Cancer Drug Pipeline with FDA Review
1M ago
KURA
Kura Oncology: Strong Financials and Promising Clinical Developments Drive Buy Rating
PremiumRatingsKura Oncology: Strong Financials and Promising Clinical Developments Drive Buy Rating
1M ago
KURA
Kura Oncology’s Promising Clinical Developments and Financial Stability Justify Buy Rating
Premium
Ratings
Kura Oncology’s Promising Clinical Developments and Financial Stability Justify Buy Rating
1M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
Premium
The Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
2M ago
KURA
Kura Oncology reports inducement grants under Nasdaq listing rule
PremiumThe Fly
Kura Oncology reports inducement grants under Nasdaq listing rule
3M ago
KURA
Kura Oncology Partners with Kyowa Kirin for Ziftomenib
PremiumCompany Announcements
Kura Oncology Partners with Kyowa Kirin for Ziftomenib
3M ago
8K
KURA
Promising Developments in Kura Oncology’s AML Treatment Drive Buy Rating
PremiumRatings
Promising Developments in Kura Oncology’s AML Treatment Drive Buy Rating
3M ago
KURA
Optimistic Outlook on Kura Oncology: Promising Developments in AML Treatment with Ziftomenib
PremiumRatings
Optimistic Outlook on Kura Oncology: Promising Developments in AML Treatment with Ziftomenib
3M ago
KURA
Kura Oncology Announces Positive Phase 1a/1b Trial Results
PremiumCompany AnnouncementsKura Oncology Announces Positive Phase 1a/1b Trial Results
3M ago
8K
KURA
Cautious Hold on Kura Oncology Amid Promising Efficacy and Safety Concerns of Ziftomenib
Premium
Ratings
Cautious Hold on Kura Oncology Amid Promising Efficacy and Safety Concerns of Ziftomenib
3M ago
KURA
Promising Clinical Trial Results and Future Prospects Justify Buy Rating for Kura Oncology
Premium
Ratings
Promising Clinical Trial Results and Future Prospects Justify Buy Rating for Kura Oncology
3M ago
KURA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >